Ana Paula de Souza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ana Paula de Souza has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Dieila Giomo de Lima
Johns Hopkins University School of Medicine, Baltimore, MD
3 shared publications - Marcelo Rocha Marques
Oral Biology Program, University of Campinas, Piracicaba, São Paulo, Brazil.
3 shared publications - Gabriell Bonifacio Borgato
Centro Universitário Nossa Senhora do Patrocínio
2 shared publications - Alessandro Santos Farias
University of Campinas
1 shared publication Aline C. Planello
Laboratory of Molecular Biology, Department of Morphology, Piracicaba Dental School, FOP, State University of Campinas, UNICAMP, Piracicaba-SP, Brazil
1 shared publicationAline Cristiane Planello
Department of Bioscience, Piracicaba Dental School, University of Campinas Piracicaba, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 18 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7366
Comparative Transcriptomic Analysis of Oral Squamous Cell Carcinoma with Progressive Cisplatin Resistance
Therapy resistance remains a major cause of cancer-related mortality. Cisplatin (cis-diamminedichloroplatinum, CDDP) is a first-line chemotherapeutic agent for oral cancer, but intrinsic and acquired resistance substantially limit its clinical efficacy. Epithelial–mesenchymal transition (EMT) has been associated with drug resistance across multiple tumor types; however, its involvement in cisplatin resistance in oral cancer remains incompletely understood. Here, we established an in vitro model of cisplatin resistance using the squamous cell carcinoma 9 (SCC-9) cell line and generated two populations with distinct resistance levels. We observed morphological and transcriptional changes consistent with EMT-related features, including increased mRNA expression of Vimentin, SNAIL1, ZEB1, ZEB2, and CDH2. Resistant cells also exhibited reduced proliferation, whereas the intermediately resistant population, cisplatin-resistant 4 (CPR4), showed greater wound closure, suggesting enhanced migratory behavior and features consistent with a hybrid-like EMT state. Conversely, the more resistant subline, cisplatin-resistant 8 (CPR8), exhibited a more stationary phenotype. Transcriptomic profiling by RNA sequencing (RNA-seq) revealed extensive differential gene expression associated with EMT and cisplatin resistance. Functional enrichment analyses identified Gene Ontology (GO) terms related to cell adhesion, extracellular matrix organization, and calcium ion binding, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed enrichment of PI3K/Akt signaling. Together, our findings support a dynamic model in which distinct EMT-related transcriptional states are associated with different levels of cisplatin resistance. This study provides insights into transcriptional changes associated with resistance acquisition and highlights candidate genes and pathways for further investigation and functional validation in oral cancer.
- 18 August 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (16) , 7366
Open AccessComparative Transcriptomic Analysis of Oral Squamous Cell Carcinoma with Progressive Cisplatin Resistance
Therapy resistance remains a major cause of cancer-related mortality. Cisplatin (cis-diamminedichloroplatinum, CDDP) is a first-line chemotherapeutic agent for oral cancer, but intrinsic and acquired resistance substantially limit its clinical efficacy. Epithelial–mesenchymal transition (EMT) has been associated with drug resistance across multiple tumor types; however, its involvement in cisplatin resistance in oral cancer remains incompletely understood. Here, we established an in vitro model of cisplatin resistance using the squamous cell carcinoma 9 (SCC-9) cell line and generated two populations with distinct resistance levels. We observed morphological and transcriptional changes consistent with EMT-related features, including increased mRNA expression of Vimentin, SNAIL1, ZEB1, ZEB2, and CDH2. Resistant cells also exhibited reduced proliferation, whereas the intermediately resistant population, cisplatin-resistant 4 (CPR4), showed greater wound closure, suggesting enhanced migratory behavior and features consistent with a hybrid-like EMT state. Conversely, the more resistant subline, cisplatin-resistant 8 (CPR8), exhibited a more stationary phenotype. Transcriptomic profiling by RNA sequencing (RNA-seq) revealed extensive differential gene expression associated with EMT and cisplatin resistance. Functional enrichment analyses identified Gene Ontology (GO) terms related to cell adhesion, extracellular matrix organization, and calcium ion binding, while Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis revealed enrichment of PI3K/Akt signaling. Together, our findings support a dynamic model in which distinct EMT-related transcriptional states are associated with different levels of cisplatin resistance. This study provides insights into transcriptional changes associated with resistance acquisition and highlights candidate genes and pathways for further investigation and functional validation in oral cancer.
- 18 December 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (2) , 910-922
Diversity and Predicted Impact of miRNAs in Human MSCs-derived Extracellular Vesicles
Extracellular vesicles (EVs) mediate intercellular communication by transferring microRNAs (miRNAs) that regulate gene expression post-transcriptionally. EVs derived from mesenchymal stem/stromal cells (MSCs) have been widely investigated, and many studies have reported the presence of miRNAs within these vesicles. However, a comprehensive analysis comparing datasets to identify miRNA functional patterns has not yet been conducted. To address this gap, we compiled and analyzed published data on miRNAs in MSCs-derived EVs to uncover common features and explore regulatory roles. A literature search was performed to identify in vitro studies involving human MSCs that provided detailed methodologies for EVs concentration and miRNA characterization. Selected miRNA datasets were used for downstream bioinformatic analyses. Validated miRNA–target gene interactions were retrieved using MultiMiR R package. Functional enrichment analyses were performed using Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways to investigate potential biological roles of the identified genes. We curated 461 studies reporting miRNAs in MSCs-derived EVs. The most studied cells were adipose-derived (ADSCs), bone marrow-derived (BMMSCs), and umbilical cord-derived MSCs (UCMSCs), with BMMSCs contributing the highest number of unique miRNAs. hsa-miR-21-5p was the most frequently reported miRNA. For ADSCs, BMMSCs, and UCMSCs, the most frequently targeted genes were ZZZ3, ZZZ3, and PTEN, respectively. Notably, ZZZ3, a chromatin regulator, was prominent in all three cells. GO analysis revealed biological process enrichment in axonogenesis, while KEGG analysis highlighted significant involvement of neutrophil extracellular trap formation and aminoacyl-tRNA biosynthesis. This study provides an integration of miRNA data from human MSCs-derived extracellular vesicles. Graphical Abstract
- 18 December 2025
- Published by Springer Nature in Stem Cell Reviews and Reports
- Vol. 22 (2) , 910-922
Diversity and Predicted Impact of miRNAs in Human MSCs-derived Extracellular Vesicles
Extracellular vesicles (EVs) mediate intercellular communication by transferring microRNAs (miRNAs) that regulate gene expression post-transcriptionally. EVs derived from mesenchymal stem/stromal cells (MSCs) have been widely investigated, and many studies have reported the presence of miRNAs within these vesicles. However, a comprehensive analysis comparing datasets to identify miRNA functional patterns has not yet been conducted. To address this gap, we compiled and analyzed published data on miRNAs in MSCs-derived EVs to uncover common features and explore regulatory roles. A literature search was performed to identify in vitro studies involving human MSCs that provided detailed methodologies for EVs concentration and miRNA characterization. Selected miRNA datasets were used for downstream bioinformatic analyses. Validated miRNA–target gene interactions were retrieved using MultiMiR R package. Functional enrichment analyses were performed using Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways to investigate potential biological roles of the identified genes. We curated 461 studies reporting miRNAs in MSCs-derived EVs. The most studied cells were adipose-derived (ADSCs), bone marrow-derived (BMMSCs), and umbilical cord-derived MSCs (UCMSCs), with BMMSCs contributing the highest number of unique miRNAs. hsa-miR-21-5p was the most frequently reported miRNA. For ADSCs, BMMSCs, and UCMSCs, the most frequently targeted genes were ZZZ3, ZZZ3, and PTEN, respectively. Notably, ZZZ3, a chromatin regulator, was prominent in all three cells. GO analysis revealed biological process enrichment in axonogenesis, while KEGG analysis highlighted significant involvement of neutrophil extracellular trap formation and aminoacyl-tRNA biosynthesis. This study provides an integration of miRNA data from human MSCs-derived extracellular vesicles. Graphical Abstract
- Open Access
- 9 July 2025
- Published by MDPI AG in Epigenomes
- Vol. 9 (3) , 23
The Fundamental Role of Nutrients for Metabolic Balance and Epigenome Integrity Maintenance
Epigenetic modifications act as crucial regulators of gene activity and are influenced by both internal and external environmental factors, with diet being the most impactful external factor. On the other hand, cellular metabolism encompasses a complex network of biochemical reactions essential for maintaining cellular function, and it impacts every cellular process. Many metabolic cofactors are critical for the activity of chromatin-modifying enzymes, influencing methylation and the global acetylation status of the epigenome. For instance, dietary nutrients, particularly those involved in one-carbon metabolism (e.g., folate, vitamins B12 and B6, riboflavin, methionine, choline, and betaine), take part in the generation of S-adenosylmethionine (SAM), which represents the main methyl donor for DNA and histone methylation; α-ketoglutarate and ascorbic acid (vitamin C) act, respectively, as a co-substrate and cofactor for Ten-eleven Translocation (TET), which is responsible for DNA demethylation; and metabolites such as Acetyl-CoA directly impact histone acetylation, linking metabolism of the TCA cycle to epigenetic regulation. Further, bioactive compounds, such as polyphenols, modulate epigenetic patterns by affecting methylation processes or targeting epigenetic enzymes. Since diet and nutrition play a critical role in shaping epigenome functions and supporting human health, this review offers a comprehensive update on recent advancements in metabolism, epigenetics, and nutrition, providing insights into how nutrients contribute to metabolic balance, epigenome integrity maintenance and, consequently, disease prevention.
- 9 July 2025
- Published by MDPI AG in Epigenomes
- Vol. 9 (3) , 23
Open AccessThe Fundamental Role of Nutrients for Metabolic Balance and Epigenome Integrity Maintenance
Epigenetic modifications act as crucial regulators of gene activity and are influenced by both internal and external environmental factors, with diet being the most impactful external factor. On the other hand, cellular metabolism encompasses a complex network of biochemical reactions essential for maintaining cellular function, and it impacts every cellular process. Many metabolic cofactors are critical for the activity of chromatin-modifying enzymes, influencing methylation and the global acetylation status of the epigenome. For instance, dietary nutrients, particularly those involved in one-carbon metabolism (e.g., folate, vitamins B12 and B6, riboflavin, methionine, choline, and betaine), take part in the generation of S-adenosylmethionine (SAM), which represents the main methyl donor for DNA and histone methylation; α-ketoglutarate and ascorbic acid (vitamin C) act, respectively, as a co-substrate and cofactor for Ten-eleven Translocation (TET), which is responsible for DNA demethylation; and metabolites such as Acetyl-CoA directly impact histone acetylation, linking metabolism of the TCA cycle to epigenetic regulation. Further, bioactive compounds, such as polyphenols, modulate epigenetic patterns by affecting methylation processes or targeting epigenetic enzymes. Since diet and nutrition play a critical role in shaping epigenome functions and supporting human health, this review offers a comprehensive update on recent advancements in metabolism, epigenetics, and nutrition, providing insights into how nutrients contribute to metabolic balance, epigenome integrity maintenance and, consequently, disease prevention.
- 1 January 2022
- Vol. 15 (3) , 131-144
Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma
The methylation and expression of DNA repair system genes has been studied in several tumor types. These genes have been associated with resistance to chemotherapy treatments by epigenetic regulation. Studies have yet to show the effects of combined therapy using an epigenetic drug (5-aza-2CdR) and cisplatin (CDDP) on DNA repair genes in oral squamous cell carcinoma (OSCC). This study proposed to investigate the effects of CDDP in combination with 5-aza-2CdR on the methylation of MGMT and MLH1 genes in oral cancer cells. Oral squamous cell carcinoma cell lineages (SCC-9, SCC-15, and SCC-25) were submitted to 72 hours of treatment: 0.1 mu M CDDP (or 4.44 mu M SCC-9), 0.1 mu M and 0.3 mu M 5-aza-2CdR (or 1 mu M and 3 mu M SCC-9), and the drugs in combination. Cell viability was assessed by MTT, DNA methylation of MGMT and MLH1 genes by Methylation Sensitivity High-Resolution Melting (MS-HRM), and the relative expression of the genes by RT-qPCR. The results show that all treatments reduced cell viability; however, in SCC-15 and SCC-9 (IC50 value), 5-aza-2CdR promotes cell sensitization to cytotoxic effect of cisplatin. The MGMT promoter region was 100% demethylated in the SCC-15 and SCC-25 cells but partially (50%) methylated in SCC-9 before drug treatment. Treatment with IC50 CDDP value kept the methylation status and decreased MGMT expression in SCC-9; MGMT gene in SCC-15 and SCC-25 cells became downregulated after treatment with 5-aza-2CdR. MLH1 was demethylated, but the treatments with low-doses and combined drugs decreased the expression in SCC-9 and SCC-25; however high doses of 5-aza-2CdR and drug combination with IC50 value CDDP increased expression of MLH1 in SCC-9. The data presented suggest that epigenetic drugs associated with chemotherapy have clinical translational potential as a therapy strategy to avoid or reverse cancer resistance, requiring further investigation.
- 1 January 2022
- Vol. 15 (3) , 131-144
Combined therapy with cisplatin and 5-AZA-2CdR modifies methylation and expression of DNA repair genes in oral squamous cell carcinoma
The methylation and expression of DNA repair system genes has been studied in several tumor types. These genes have been associated with resistance to chemotherapy treatments by epigenetic regulation. Studies have yet to show the effects of combined therapy using an epigenetic drug (5-aza-2CdR) and cisplatin (CDDP) on DNA repair genes in oral squamous cell carcinoma (OSCC). This study proposed to investigate the effects of CDDP in combination with 5-aza-2CdR on the methylation of MGMT and MLH1 genes in oral cancer cells. Oral squamous cell carcinoma cell lineages (SCC-9, SCC-15, and SCC-25) were submitted to 72 hours of treatment: 0.1 mu M CDDP (or 4.44 mu M SCC-9), 0.1 mu M and 0.3 mu M 5-aza-2CdR (or 1 mu M and 3 mu M SCC-9), and the drugs in combination. Cell viability was assessed by MTT, DNA methylation of MGMT and MLH1 genes by Methylation Sensitivity High-Resolution Melting (MS-HRM), and the relative expression of the genes by RT-qPCR. The results show that all treatments reduced cell viability; however, in SCC-15 and SCC-9 (IC50 value), 5-aza-2CdR promotes cell sensitization to cytotoxic effect of cisplatin. The MGMT promoter region was 100% demethylated in the SCC-15 and SCC-25 cells but partially (50%) methylated in SCC-9 before drug treatment. Treatment with IC50 CDDP value kept the methylation status and decreased MGMT expression in SCC-9; MGMT gene in SCC-15 and SCC-25 cells became downregulated after treatment with 5-aza-2CdR. MLH1 was demethylated, but the treatments with low-doses and combined drugs decreased the expression in SCC-9 and SCC-25; however high doses of 5-aza-2CdR and drug combination with IC50 value CDDP increased expression of MLH1 in SCC-9. The data presented suggest that epigenetic drugs associated with chemotherapy have clinical translational potential as a therapy strategy to avoid or reverse cancer resistance, requiring further investigation.
- 1 August 2020
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 130 (2) , 181-190
Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2’-deoxycytidine
- 1 August 2020
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 130 (2) , 181-190
Loss of PTEN sensitizes head and neck squamous cell carcinoma to 5-AZA-2’-deoxycytidine
- 1 May 2019
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 127 (5) , 425-432
5-Aza-CdR promotes partial MGMT demethylation and modifies expression of different genes in oral squamous cell carcinoma
- 1 May 2019
- Published by Elsevier in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 127 (5) , 425-432
5-Aza-CdR promotes partial MGMT demethylation and modifies expression of different genes in oral squamous cell carcinoma
- 16 July 2002
- Published by Wiley in European Journal of Immunogenetics
- Vol. 29 (4) , 293-296
Frequencies of the -330 (T → G) IL-2 and -590 (T → C) IL-4 gene polymorphisms in a population from south-eastern Brazil
Polymorphisms in the promoter regions of cytokine genes may affect their transcription. A T/G substitution at position -330 of the interleukin-2 (IL-2) gene and a T/C substitution at position -590 of the interleukin-4 (IL-4) gene have been described previously. The -590 (T --> C) IL-4 gene polymorphism was associated with asthma and atopy in US and Japanese populations. Population genetics is a useful tool for determination of the biological significance of genetic polymorphisms. The aim of this study was to investigate the frequencies of polymorphisms in the promoter regions of the IL-2 and IL-4 genes in a population from south-eastern Brazil and to compare them with those published for other populations. Allele frequencies were estimated in 114 unrelated individuals from São Paulo State. These subjects had an average age of 41.2 years (+/- 12.4 years) and the ethnic composition of the sample was: 78.07% Caucasian, 11.4% Black and 10.53% Mulatto. DNA from subjects was extracted from epithelial buccal cells, and the PCR-RFLP technique was employed to investigate the -330 (T --> G) IL-2 and -590 (T --> C) IL-4 gene polymorphisms. The allele frequency of the IL-2 gene polymorphism obtained in our study was similar to that found in UK Caucasoid groups. The T allele frequency of the IL-4 gene polymorphism observed in the Caucasian Brazilian group was similar to that found in UK and Australian populations, while the frequency observed for the Black Brazilian group was similar to that found in Japanese and Kuwaiti Arab populations. The results for the -330 (T --> G) IL-2 and -590 (T --> C) IL-4 polymorphisms are consistent with the high contribution of European lineages to the population in south-eastern Brazil.
- 16 July 2002
- Published by Wiley in European Journal of Immunogenetics
- Vol. 29 (4) , 293-296
Frequencies of the -330 (T → G) IL-2 and -590 (T → C) IL-4 gene polymorphisms in a population from south-eastern Brazil
Polymorphisms in the promoter regions of cytokine genes may affect their transcription. A T/G substitution at position -330 of the interleukin-2 (IL-2) gene and a T/C substitution at position -590 of the interleukin-4 (IL-4) gene have been described previously. The -590 (T --> C) IL-4 gene polymorphism was associated with asthma and atopy in US and Japanese populations. Population genetics is a useful tool for determination of the biological significance of genetic polymorphisms. The aim of this study was to investigate the frequencies of polymorphisms in the promoter regions of the IL-2 and IL-4 genes in a population from south-eastern Brazil and to compare them with those published for other populations. Allele frequencies were estimated in 114 unrelated individuals from São Paulo State. These subjects had an average age of 41.2 years (+/- 12.4 years) and the ethnic composition of the sample was: 78.07% Caucasian, 11.4% Black and 10.53% Mulatto. DNA from subjects was extracted from epithelial buccal cells, and the PCR-RFLP technique was employed to investigate the -330 (T --> G) IL-2 and -590 (T --> C) IL-4 gene polymorphisms. The allele frequency of the IL-2 gene polymorphism obtained in our study was similar to that found in UK Caucasoid groups. The T allele frequency of the IL-4 gene polymorphism observed in the Caucasian Brazilian group was similar to that found in UK and Australian populations, while the frequency observed for the Black Brazilian group was similar to that found in Japanese and Kuwaiti Arab populations. The results for the -330 (T --> G) IL-2 and -590 (T --> C) IL-4 polymorphisms are consistent with the high contribution of European lineages to the population in south-eastern Brazil.